These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 2823581)

  • 1. Adenosine and eicosanoid release from immunologically challenged human lung fragments.
    Viganò T; Toia A; Galli G; Berti F; Crivellari MT; Mezzetti M; Folco GC
    Adv Prostaglandin Thromboxane Leukot Res; 1987; 17B():992-6. PubMed ID: 2823581
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of the release of prostaglandins, thromboxanes, and leukotrienes from anaphylactic lungs by a platelet-activating factor (PAF) antagonist and its stimulation by PAF.
    Sirois P; Harczy M; Braquet P; Borgeat P; Maclouf J; Pradelles P
    Adv Prostaglandin Thromboxane Leukot Res; 1987; 17B():1033-7. PubMed ID: 2823554
    [No Abstract]   [Full Text] [Related]  

  • 3. Anaphylactic release of platelet activating factor acether and eicosanoids from lungs of guinea pigs sensitized to ovalbumin aerosol.
    Parente L; Fitzgerald MF; Moncada S
    Adv Prostaglandin Thromboxane Leukot Res; 1987; 17A():171-6. PubMed ID: 2821756
    [No Abstract]   [Full Text] [Related]  

  • 4. Lung hypersensitivity responses: dissociation of human lung mast cell leukotriene C4 (LTC4) from histamine release.
    Schulman ES; Anderson CL
    Prog Clin Biol Res; 1985; 199():209-20. PubMed ID: 2415994
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of the beta-2 adrenergic agonist fenoterol on the release of leukotrienes and prostaglandin D2 from human lung parenchyma.
    Viganò T; Sautebin L; Crivellari MT; Galli G; Mezzetti M; Folco GC
    Wien Klin Wochenschr; 1986 Feb; 98(4):120-22. PubMed ID: 3085356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mast cells and mast cell mediators in models of airway disease.
    Peters SP; Naclerio RM; Freeland HS; Togias A; Schleimer RP; MacGlashan DW; Kagey-Sobotka A; Fox CC; Adkinson NF; Lichtenstein LM
    Prog Clin Biol Res; 1985; 199():153-61. PubMed ID: 2999818
    [No Abstract]   [Full Text] [Related]  

  • 7. Release of leukotrienes, induced by the Ca++ ionophore A23187, from human lung parenchyma in vitro.
    Sautebin L; Viganò T; Grassi E; Crivellari MT; Galli G; Berti F; Mezzetti M; Folco G
    J Pharmacol Exp Ther; 1985 Jul; 234(1):217-21. PubMed ID: 2989505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of mast cells in the pathogenesis of asthma.
    Holgate ST
    Bull Eur Physiopathol Respir; 1985; 21(5):449-62. PubMed ID: 2415192
    [No Abstract]   [Full Text] [Related]  

  • 9. Stimulus-related difference in the formation of leukotrienes and PGD2 after immunological and non-immunological challenge of human lung parenchyma "in vitro".
    Viganò T; Sautebin L; Magni F; Crivellari MT; Paganelli R; Galli G; Berti F; Folco G
    Prostaglandins Leukot Med; 1986 Aug; 23(2-3):109-15. PubMed ID: 3020580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The release of 35-S-labelled material and SRS-A from immunologically challenged guinea-pig lungs.
    Dawson W; Lewis RL; Tomlinson R
    J Physiol; 1975 May; 247(1):37P-38P. PubMed ID: 1138065
    [No Abstract]   [Full Text] [Related]  

  • 11. Profile and sites of eicosanoid release in experimental necrotizing enterocolitis.
    Miller MJ; Clark DA
    Adv Prostaglandin Thromboxane Leukot Res; 1989; 19():556-9. PubMed ID: 2546396
    [No Abstract]   [Full Text] [Related]  

  • 12. Structural determination of leukotrienes and lipoxins.
    Samuelsson B; Hammarström S; Hamberg M; Serhan CN
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 14():45-71. PubMed ID: 2992247
    [No Abstract]   [Full Text] [Related]  

  • 13. Advances in the analysis of eicosanoids by ELISA and GC/MS/MS.
    Frölich JC; Sawada M; Bochmann G; Oelz O
    Adv Prostaglandin Thromboxane Leukot Res; 1986; 16():363-72. PubMed ID: 2949561
    [No Abstract]   [Full Text] [Related]  

  • 14. Binding sites for histamine and sulfidopeptide leukotrienes in normal and hypersensitized human lung fragments.
    Vigano' T; Nicosia S; Accomazzo MR; Crivellari MT; Oliva D; Verga A; Mezzetti M; Folco G
    Adv Prostaglandin Thromboxane Leukot Res; 1990; 20():187-92. PubMed ID: 2144691
    [No Abstract]   [Full Text] [Related]  

  • 15. Prostaglandins, related compounds, and the perinatal pulmonary circulation.
    Philips JB; Lyrene RK
    Clin Perinatol; 1984 Oct; 11(3):565-79. PubMed ID: 6386270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potentiation of SRS-A release from guinea pig chopped lung by substrates for arachidonate lipoxygenase.
    Piper PJ; Tippins JR; Morris HR; Taylor GW
    Adv Prostaglandin Thromboxane Res; 1980; 6():121-4. PubMed ID: 6770588
    [No Abstract]   [Full Text] [Related]  

  • 17. Prostaglandin synthetase inhibition and formation of lipoxygenase products in immunologically challenged normal human lung parenchyma.
    Vigano T; Toia A; Crivellari MT; Galli G; Mezzetti M; Folco GC
    Eicosanoids; 1988; 1(2):73-7. PubMed ID: 3152489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of the generation and release of leukotrienes from leukocytes.
    Lewis RA
    Prog Clin Biol Res; 1985; 199():163-72. PubMed ID: 2999819
    [No Abstract]   [Full Text] [Related]  

  • 19. The relationship between prostaglandin-like substances and SRS-A released from immunologically challenged lungs [proceedings].
    Boot JR; Brockwell AD; Dawson W; Sweatman WJ
    Br J Pharmacol; 1977 Mar; 59(3):444P-445P. PubMed ID: 843693
    [No Abstract]   [Full Text] [Related]  

  • 20. Arachidonic acid metabolites and endothelial injury: studies with cultures of human endothelial cells.
    Johnson AR; Revtyak G; Campbell WB
    Fed Proc; 1985 Jan; 44(1 Pt 1):19-24. PubMed ID: 2981729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.